Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the <scp>IG‐IBD LIVE</scp> study - Concepedia

Concepedia

Publication | Open Access

Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the <scp>IG‐IBD LIVE</scp> study

DOI Full Paper Access

43

Citations

44

References

2022

Year

Daniela Pugliese, Giuseppe Privitera, Federica Crispino, Nicolò Mezzina, Fabiana Castiglione, Gionata Fiorino, Lucrezia Laterza, Anna Viola, Lorenzo Bertani, Flavio Caprioli,

Alimentary Pharmacology & Therapeutics

Abstract

Vedolizumab can be considered a safe option in elderly IBD patients. Its effectiveness in elderly UC patients may be reduced, while no age-dependent effect on effectiveness was observed in CD.

References

	Year	Citations

Page 1